concizumab
Novo Nordisk
['explorer']
melissa frei-jones reports results from the phase 3 explorer7 trial on concizumab, an anti-tissue factor pathway inhibitor in haemophilia pts with inhibitors. 0 abr reported, but questions from audience about safety and adverse effects #ash22 
The Lancet Haematology is a world-leading #haematology journal publishing peer-reviewed research and reviews, opinion, and news. #hematology